Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 590 entries
Sorted by: Best Match Show Resources per page
Enhanced catalytic activity of polyethylenedioxythiophene towards tri-iodide reduction in DSSCs via 1-dimensional alignment using hollow carbon nanofibers.

Nanoscale

Anothumakkool B, Game O, Bhange SN, Kumari T, Ogale SB, Kurungot S.
PMID: 25072706
Nanoscale. 2014 Sep 07;6(17):10332-9. doi: 10.1039/c4nr00717d.

Here, we report a highly conducting 1-dimensionally (1-D) aligned polyethylenedioxythiophene (PEDOT) along the inner and outer surfaces of a hollow carbon nanofiber (CNF) and its application as a counter electrode in a dye sensitized solar cell (DSSC). The hybrid...

Cite
Anothumakkool B, Game O, Bhange SN, et al. Enhanced catalytic activity of polyethylenedioxythiophene towards tri-iodide reduction in DSSCs via 1-dimensional alignment using hollow carbon nanofibers. Nanoscale. 2014;6(17):10332-9doi: 10.1039/c4nr00717d.
Anothumakkool, B., Game, O., Bhange, S. N., Kumari, T., Ogale, S. B., & Kurungot, S. (2014). Enhanced catalytic activity of polyethylenedioxythiophene towards tri-iodide reduction in DSSCs via 1-dimensional alignment using hollow carbon nanofibers. Nanoscale, 6(17), 10332-9. https://doi.org/10.1039/c4nr00717d
Anothumakkool, Bihag, et al. "Enhanced catalytic activity of polyethylenedioxythiophene towards tri-iodide reduction in DSSCs via 1-dimensional alignment using hollow carbon nanofibers." Nanoscale vol. 6,17 (2014): 10332-9. doi: https://doi.org/10.1039/c4nr00717d
Anothumakkool B, Game O, Bhange SN, Kumari T, Ogale SB, Kurungot S. Enhanced catalytic activity of polyethylenedioxythiophene towards tri-iodide reduction in DSSCs via 1-dimensional alignment using hollow carbon nanofibers. Nanoscale. 2014 Sep 07;6(17):10332-9. doi: 10.1039/c4nr00717d. PMID: 25072706.
Copy Download .nbib Format: NLM
Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer.

Annals of surgical oncology

Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T.
PMID: 26170193
Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8.

No abstract available.

Cite
Aoyama T, Kawabe T, Fujikawa H, et al. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015;22:S1616doi: 10.1245/s10434-015-4732-8.
Aoyama, T., Kawabe, T., Fujikawa, H., Hayashi, T., Yamada, T., Tsuchida, K., Yukawa, N., Oshima, T., Rino, Y., Masuda, M., Ogata, T., Cho, H., & Yoshikawa, T. (2015). Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Annals of surgical oncology, 22S1616. https://doi.org/10.1245/s10434-015-4732-8
Aoyama, Toru, et al. "Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer." Annals of surgical oncology vol. 22 (2015): S1616. doi: https://doi.org/10.1245/s10434-015-4732-8
Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8. PMID: 26170193.
Copy Download .nbib Format: NLM
Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014.

Clinical and experimental nephrology

Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S.
PMID: 27358079
Clin Exp Nephrol. 2016 Aug;20(4):510. doi: 10.1007/s10157-016-1285-5.

No abstract available.

Cite
Horie S, Mochizuki T, Muto S, et al. Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol. 2016;20(4):510doi: 10.1007/s10157-016-1285-5.
Horie, S., Mochizuki, T., Muto, S., Hanaoka, K., Fukushima, Y., Narita, I., Nutahara, K., Tsuchiya, K., Tsuruya, K., Kamura, K., Nishio, S., Suwabe, T., Ubara, Y., Ishimura, E., Nakanishi, K., Furukawa, K., Kimura, K., & Matsuo, S. (2016). Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clinical and experimental nephrology, 20(4), 510. https://doi.org/10.1007/s10157-016-1285-5
Horie, Shigeo, et al. "Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014." Clinical and experimental nephrology vol. 20,4 (2016): 510. doi: https://doi.org/10.1007/s10157-016-1285-5
Horie S, Mochizuki T, Muto S, Hanaoka K, Fukushima Y, Narita I, Nutahara K, Tsuchiya K, Tsuruya K, Kamura K, Nishio S, Suwabe T, Ubara Y, Ishimura E, Nakanishi K, Furukawa K, Kimura K, Matsuo S. Erratum to: Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol. 2016 Aug;20(4):510. doi: 10.1007/s10157-016-1285-5. PMID: 27358079; PMCID: PMC6828247.
Copy Download .nbib Format: NLM
ANCA-Associated Vasculitis in a Patient with Systematic Sclerosis and Sjögren's Syndrome: A Case Report.

Case reports in nephrology and dialysis

Kubota K, Ueno T, Mise K, Hazue R, Suwabe T, Kikuchi K, Hoshino J, Sumida K, Hayami N, Takaichi K, Fujii T, Ohashi K, Nonomura Y, Ubara Y.
PMID: 26120576
Case Rep Nephrol Dial. 2015 May 05;5(2):113-7. doi: 10.1159/000381946. eCollection 2015.

A 65-year-old woman with a limited form of systematic sclerosis (SSc) and Sjögren's syndrome (SS) was admitted to our hospital for the evaluation of renal dysfunction. Her serum creatinine was 1.6 mg/dl, proteinuria was 1.6 g/day, and the urine...

Cite
Kubota K, Ueno T, Mise K, et al. ANCA-Associated Vasculitis in a Patient with Systematic Sclerosis and Sjögren's Syndrome: A Case Report. Case Rep Nephrol Dial. 2015;5(2):113-7doi: 10.1159/000381946.
Kubota, K., Ueno, T., Mise, K., Hazue, R., Suwabe, T., Kikuchi, K., Hoshino, J., Sumida, K., Hayami, N., Takaichi, K., Fujii, T., Ohashi, K., Nonomura, Y., & Ubara, Y. (2015). ANCA-Associated Vasculitis in a Patient with Systematic Sclerosis and Sjögren's Syndrome: A Case Report. Case reports in nephrology and dialysis, 5(2), 113-7. https://doi.org/10.1159/000381946
Kubota, Keiichi, et al. "ANCA-Associated Vasculitis in a Patient with Systematic Sclerosis and Sjögren's Syndrome: A Case Report." Case reports in nephrology and dialysis vol. 5,2 (2015): 113-7. doi: https://doi.org/10.1159/000381946
Kubota K, Ueno T, Mise K, Hazue R, Suwabe T, Kikuchi K, Hoshino J, Sumida K, Hayami N, Takaichi K, Fujii T, Ohashi K, Nonomura Y, Ubara Y. ANCA-Associated Vasculitis in a Patient with Systematic Sclerosis and Sjögren's Syndrome: A Case Report. Case Rep Nephrol Dial. 2015 May 05;5(2):113-7. doi: 10.1159/000381946. eCollection 2015. PMID: 26120576; PMCID: PMC4464031.
Copy Download .nbib Format: NLM
Delayed Visual Feedback of One's Own Action Promotes Sense of Control for Auditory Events.

Frontiers in integrative neuroscience

Kawabe T.
PMID: 26635552
Front Integr Neurosci. 2015 Nov 19;9:57. doi: 10.3389/fnint.2015.00057. eCollection 2015.

Sense of control refers to one's feelings to control environmental events through one's own action. A prevailing view is that the sense of control is strong (or is not diminished) when predicted sensory signals, which are generated in motor...

Cite
Kawabe T. Delayed Visual Feedback of One's Own Action Promotes Sense of Control for Auditory Events. Front Integr Neurosci. 2015;9:57doi: 10.3389/fnint.2015.00057.
Kawabe, T. (2015). Delayed Visual Feedback of One's Own Action Promotes Sense of Control for Auditory Events. Frontiers in integrative neuroscience, 957. https://doi.org/10.3389/fnint.2015.00057
Kawabe, Takahiro. "Delayed Visual Feedback of One's Own Action Promotes Sense of Control for Auditory Events." Frontiers in integrative neuroscience vol. 9 (2015): 57. doi: https://doi.org/10.3389/fnint.2015.00057
Kawabe T. Delayed Visual Feedback of One's Own Action Promotes Sense of Control for Auditory Events. Front Integr Neurosci. 2015 Nov 19;9:57. doi: 10.3389/fnint.2015.00057. eCollection 2015. PMID: 26635552; PMCID: PMC4652057.
Copy Download .nbib Format: NLM
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade.

Hepatology research : the official journal of the Japan Society of Hepatology

Hiraoka A, Kumada T, Hirooka M, Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, Tada T, Toyoda H, Nouso K, Joko K, Kawasaki H, Hiasa Y, Michitaka K.
PMID: 28628718
Hepatol Res. 2018 Feb;48(3):E61-E67. doi: 10.1111/hepr.12927. Epub 2017 Aug 02.

AIM: To evaluate the efficacy of the newly proposed albumin-bilirubin (ALBI) grade for therapy selection, clinical features of patients treated with radiofrequency ablation (RFA) were elucidated.METHODS: From 2000 to 2015, 1101 patients with HCC (

Cite
Hiraoka A, Kumada T, Hirooka M, et al. A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade. Hepatol Res. 2017;48(3):E61-E67doi: 10.1111/hepr.12927.
Hiraoka, A., Kumada, T., Hirooka, M., Tsuji, K., Itobayashi, E., Kariyama, K., Ishikawa, T., Tajiri, K., Ochi, H., Tada, T., Toyoda, H., Nouso, K., Joko, K., Kawasaki, H., Hiasa, Y., Michitaka, K. (2018). A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade. Hepatology research : the official journal of the Japan Society of Hepatology, 48(3), E61-E67. https://doi.org/10.1111/hepr.12927
Hiraoka, Atsushi, et al. "A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade." Hepatology research : the official journal of the Japan Society of Hepatology vol. 48,3 (2018): E61-E67. doi: https://doi.org/10.1111/hepr.12927
Hiraoka A, Kumada T, Hirooka M, Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, Tada T, Toyoda H, Nouso K, Joko K, Kawasaki H, Hiasa Y, Michitaka K. A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade. Hepatol Res. 2018 Feb;48(3):E61-E67. doi: 10.1111/hepr.12927. Epub 2017 Aug 02. PMID: 28628718.
Copy Download .nbib Format: NLM
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis.

Neuro-oncology practice

Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI.
PMID: 27833757
Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07.

BACKGROUND: Brain radiation necrosis (BRN) can be a complication of radiotherapy for primary and secondary brain tumors, as well as head and neck tumors. Since vascular endothelial growth factor (VEGF) is also a vascular permeability factor in the brain,...

Cite
Furuse M, Nonoguchi N, Kuroiwa T, et al. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016;3(4):272-280doi: 10.1093/nop/npv064.
Furuse, M., Nonoguchi, N., Kuroiwa, T., Miyamoto, S., Arakawa, Y., Shinoda, J., Miwa, K., Iuchi, T., Tsuboi, K., Houkin, K., Terasaka, S., Tabei, Y., Nakamura, H., Nagane, M., Sugiyama, K., Terasaki, M., Abe, T., Narita, Y., Saito, N., Mukasa, A., Ogasawara, K., Beppu, T., Kumabe, T., Nariai, T., Tsuyuguchi, N., Nakatani, E., Kurisu, S., Nakagawa, Y., & Miyatake, S. I. (2016). A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neuro-oncology practice, 3(4), 272-280. https://doi.org/10.1093/nop/npv064
Furuse, Motomasa, et al. "A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis." Neuro-oncology practice vol. 3,4 (2016): 272-280. doi: https://doi.org/10.1093/nop/npv064
Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07. PMID: 27833757; PMCID: PMC5099992.
Copy Download .nbib Format: NLM
Correction: New function of aldoxime dehydratase: Redox catalysis and the formation of an expected product.

PloS one

Yamada M, Hashimoto Y, Kumano T, Tsujimura S, Kobayashi M.
PMID: 28558054
PLoS One. 2017 May 30;12(5):e0178974. doi: 10.1371/journal.pone.0178974. eCollection 2017.

[This corrects the article DOI: 10.1371/journal.pone.0175846.].

Cite
Yamada M, Hashimoto Y, Kumano T, et al. Correction: New function of aldoxime dehydratase: Redox catalysis and the formation of an expected product. PLoS One. 2017;12(5):e0178974doi: 10.1371/journal.pone.0178974.
Yamada, M., Hashimoto, Y., Kumano, T., Tsujimura, S., & Kobayashi, M. (2017). Correction: New function of aldoxime dehydratase: Redox catalysis and the formation of an expected product. PloS one, 12(5), e0178974. https://doi.org/10.1371/journal.pone.0178974
Yamada, Masatoshi, et al. "Correction: New function of aldoxime dehydratase: Redox catalysis and the formation of an expected product." PloS one vol. 12,5 (2017): e0178974. doi: https://doi.org/10.1371/journal.pone.0178974
Yamada M, Hashimoto Y, Kumano T, Tsujimura S, Kobayashi M. Correction: New function of aldoxime dehydratase: Redox catalysis and the formation of an expected product. PLoS One. 2017 May 30;12(5):e0178974. doi: 10.1371/journal.pone.0178974. eCollection 2017. PMID: 28558054; PMCID: PMC5448797.
Copy Download .nbib Format: NLM
Prediction of hepatic cyst recurrence after minocycline hydrochloride aspiration sclerotherapy using cyst computed tomography values.

Hepatology research : the official journal of the Japan Society of Hepatology

Iijima T, Suwabe T, Sumida K, Hayami N, Mise K, Hoshino J, Takaichi K, Ubara Y.
PMID: 27316759
Hepatol Res. 2017 Apr;47(5):419-424. doi: 10.1111/hepr.12763. Epub 2016 Jul 27.

AIM: Polycystic liver disease (PLD) occasionally leads to abdominal pain, distention, and discomfort due to massively enlarged cysts. Patients with a small number of large liver cysts, which correspond to Gigot's classification type 1 PLD, are reported to be...

Cite
Iijima T, Suwabe T, Sumida K, et al. Prediction of hepatic cyst recurrence after minocycline hydrochloride aspiration sclerotherapy using cyst computed tomography values. Hepatol Res. 2016;47(5):419-424doi: 10.1111/hepr.12763.
Iijima, T., Suwabe, T., Sumida, K., Hayami, N., Mise, K., Hoshino, J., Takaichi, K., & Ubara, Y. (2017). Prediction of hepatic cyst recurrence after minocycline hydrochloride aspiration sclerotherapy using cyst computed tomography values. Hepatology research : the official journal of the Japan Society of Hepatology, 47(5), 419-424. https://doi.org/10.1111/hepr.12763
Iijima, Takashi, et al. "Prediction of hepatic cyst recurrence after minocycline hydrochloride aspiration sclerotherapy using cyst computed tomography values." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,5 (2017): 419-424. doi: https://doi.org/10.1111/hepr.12763
Iijima T, Suwabe T, Sumida K, Hayami N, Mise K, Hoshino J, Takaichi K, Ubara Y. Prediction of hepatic cyst recurrence after minocycline hydrochloride aspiration sclerotherapy using cyst computed tomography values. Hepatol Res. 2017 Apr;47(5):419-424. doi: 10.1111/hepr.12763. Epub 2016 Jul 27. PMID: 27316759.
Copy Download .nbib Format: NLM
Severe hypoglycemia associated with insulin-like growth factor II-producing liver metastasis from gastric carcinoma treated with overnight total parenteral nutrition via a central vein catheter reserve port.

Clinical journal of gastroenterology

Koizumi Y, Hiraoka A, Michitaka K, Tazuya N, Ichiryu M, Nakahara H, Ochi H, Tanabe A, Hidaka S, Kodama A, Uehara T, Hasebe A, Miyamoto Y, Ninomiya T, Kumagi T, Abe M, Matsuura B, Horiike N, Hiasa Y, Onji M.
PMID: 26190708
Clin J Gastroenterol. 2011 Apr;4(2):68-72. doi: 10.1007/s12328-010-0200-y. Epub 2011 Jan 21.

Hypoglycemia caused by insulin-like growth factor II is difficult to control. A 77-year-old woman was diagnosed with gastric cancer and multiple liver metastases in September 2006 and underwent chemotherapy; however, at that time there were no symptoms of hypoglycemia....

Cite
Koizumi Y, Hiraoka A, Michitaka K, et al. Severe hypoglycemia associated with insulin-like growth factor II-producing liver metastasis from gastric carcinoma treated with overnight total parenteral nutrition via a central vein catheter reserve port. Clin J Gastroenterol. 2011;4(2):68-72doi: 10.1007/s12328-010-0200-y.
Koizumi, Y., Hiraoka, A., Michitaka, K., Tazuya, N., Ichiryu, M., Nakahara, H., Ochi, H., Tanabe, A., Hidaka, S., Kodama, A., Uehara, T., Hasebe, A., Miyamoto, Y., Ninomiya, T., Kumagi, T., Abe, M., Matsuura, B., Horiike, N., Hiasa, Y., & Onji, M. (2011). Severe hypoglycemia associated with insulin-like growth factor II-producing liver metastasis from gastric carcinoma treated with overnight total parenteral nutrition via a central vein catheter reserve port. Clinical journal of gastroenterology, 4(2), 68-72. https://doi.org/10.1007/s12328-010-0200-y
Koizumi, Yohei, et al. "Severe hypoglycemia associated with insulin-like growth factor II-producing liver metastasis from gastric carcinoma treated with overnight total parenteral nutrition via a central vein catheter reserve port." Clinical journal of gastroenterology vol. 4,2 (2011): 68-72. doi: https://doi.org/10.1007/s12328-010-0200-y
Koizumi Y, Hiraoka A, Michitaka K, Tazuya N, Ichiryu M, Nakahara H, Ochi H, Tanabe A, Hidaka S, Kodama A, Uehara T, Hasebe A, Miyamoto Y, Ninomiya T, Kumagi T, Abe M, Matsuura B, Horiike N, Hiasa Y, Onji M. Severe hypoglycemia associated with insulin-like growth factor II-producing liver metastasis from gastric carcinoma treated with overnight total parenteral nutrition via a central vein catheter reserve port. Clin J Gastroenterol. 2011 Apr;4(2):68-72. doi: 10.1007/s12328-010-0200-y. Epub 2011 Jan 21. PMID: 26190708.
Copy Download .nbib Format: NLM
Endovascular treatment is effective against acute mesenteric ischemia complicated with metabolic diseases.

Clinical journal of gastroenterology

Watanabe T, Hiasa Y, Torisu M, Shimizu T, Yamamoto Y, Kawasaki K, Higaki N, Murakami H, Kumagi T, Abe M, Furukawa S, Matsuura B, Ikeda Y, Tanaka H, Mochizuki T, Onji M.
PMID: 26189524
Clin J Gastroenterol. 2011 Aug;4(4):223-229. doi: 10.1007/s12328-011-0236-7. Epub 2011 Jun 29.

A 77-year-old man with hypertension, diabetes mellitus, ischemic heart disease and a smoking habit presented at our hospital with sudden abdominal pain. Computed tomography indicated edematous swelling and pneumatosis of the intestinal wall in a localized area of the...

Cite
Watanabe T, Hiasa Y, Torisu M, et al. Endovascular treatment is effective against acute mesenteric ischemia complicated with metabolic diseases. Clin J Gastroenterol. 2011;4(4):223-229doi: 10.1007/s12328-011-0236-7.
Watanabe, T., Hiasa, Y., Torisu, M., Shimizu, T., Yamamoto, Y., Kawasaki, K., Higaki, N., Murakami, H., Kumagi, T., Abe, M., Furukawa, S., Matsuura, B., Ikeda, Y., Tanaka, H., Mochizuki, T., & Onji, M. (2011). Endovascular treatment is effective against acute mesenteric ischemia complicated with metabolic diseases. Clinical journal of gastroenterology, 4(4), 223-229. https://doi.org/10.1007/s12328-011-0236-7
Watanabe, Takao, et al. "Endovascular treatment is effective against acute mesenteric ischemia complicated with metabolic diseases." Clinical journal of gastroenterology vol. 4,4 (2011): 223-229. doi: https://doi.org/10.1007/s12328-011-0236-7
Watanabe T, Hiasa Y, Torisu M, Shimizu T, Yamamoto Y, Kawasaki K, Higaki N, Murakami H, Kumagi T, Abe M, Furukawa S, Matsuura B, Ikeda Y, Tanaka H, Mochizuki T, Onji M. Endovascular treatment is effective against acute mesenteric ischemia complicated with metabolic diseases. Clin J Gastroenterol. 2011 Aug;4(4):223-229. doi: 10.1007/s12328-011-0236-7. Epub 2011 Jun 29. PMID: 26189524.
Copy Download .nbib Format: NLM
Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis.

Clinical journal of gastroenterology

Kumagi T, Heathcote EJ.
PMID: 26193696
Clin J Gastroenterol. 2008 Dec;1(4):160-163. doi: 10.1007/s12328-008-0027-y. Epub 2008 Sep 26.

A 56-year-old gentleman with benign recurrent intrahepatic cholestasis (BRIC) suffered from recurrent episodes of pruritus for over 40 years. The treatment prescribed, namely cholestyramine, was minimally effective. However, rifampin 150 mg b.i.d promptly and completely relieved his severe pruritus....

Cite
Kumagi T, Heathcote EJ. Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis. Clin J Gastroenterol. 2008;1(4):160-163doi: 10.1007/s12328-008-0027-y.
Kumagi, T., & Heathcote, E. J. (2008). Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis. Clinical journal of gastroenterology, 1(4), 160-163. https://doi.org/10.1007/s12328-008-0027-y
Kumagi, Teru, and Heathcote, E Jenny. "Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis." Clinical journal of gastroenterology vol. 1,4 (2008): 160-163. doi: https://doi.org/10.1007/s12328-008-0027-y
Kumagi T, Heathcote EJ. Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis. Clin J Gastroenterol. 2008 Dec;1(4):160-163. doi: 10.1007/s12328-008-0027-y. Epub 2008 Sep 26. PMID: 26193696.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 590 entries